Esperion Therapeutics, Inc. (ESPR): Price and Financial Metrics
ESPR Price/Volume Stats
| Current price | $1.74 | 52-week high | $3.94 |
| Prev. close | $1.69 | 52-week low | $1.47 |
| Day low | $1.67 | Volume | 4,387,330 |
| Day high | $1.75 | Avg. volume | 4,278,205 |
| 50-day MA | $1.84 | Dividend yield | N/A |
| 200-day MA | $2.12 | Market Cap | 344.26M |
ESPR Stock Price Chart Interactive Chart >
Esperion Therapeutics, Inc. (ESPR) Company Bio
Esperion Therapeutics is focused on developing and commercializing first-in-class, oral, LDL-cholesterol-lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. The company was founded in 1998 and is based in Ann Arbor, Michigan.
ESPR Price Returns
| 1-mo | -4.40% |
| 3-mo | -24.35% |
| 6-mo | 8.07% |
| 1-year | -24.02% |
| 3-year | -64.49% |
| 5-year | -95.33% |
| YTD | -20.91% |
| 2024 | -26.42% |
| 2023 | -52.01% |
| 2022 | 24.60% |
| 2021 | -80.77% |
| 2020 | -56.40% |
Continue Researching ESPR
Want to do more research on Esperion Therapeutics Inc's stock and its price? Try the links below:Esperion Therapeutics Inc (ESPR) Stock Price | Nasdaq
Esperion Therapeutics Inc (ESPR) Stock Quote, History and News - Yahoo Finance
Esperion Therapeutics Inc (ESPR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...